Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,394 | 1,423 | 99.6% |
| Education | $81.80 | 10 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,575 | 187 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,377 | 162 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,200 | 115 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,093 | 130 | $0 (2024) |
| Lilly USA, LLC | $1,516 | 96 | $0 (2024) |
| ABBVIE INC. | $1,389 | 100 | $0 (2024) |
| Amgen Inc. | $1,307 | 67 | $0 (2024) |
| PFIZER INC. | $1,065 | 125 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $990.10 | 72 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $583.50 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,546 | 187 | AstraZeneca Pharmaceuticals LP ($517.27) |
| 2023 | $3,131 | 182 | ABBVIE INC. ($457.15) |
| 2022 | $3,056 | 191 | Boehringer Ingelheim Pharmaceuticals, Inc. ($375.43) |
| 2021 | $3,082 | 212 | GlaxoSmithKline, LLC. ($440.00) |
| 2020 | $1,610 | 92 | Novo Nordisk Inc ($371.36) |
| 2019 | $2,430 | 174 | AstraZeneca Pharmaceuticals LP ($398.94) |
| 2018 | $2,279 | 206 | PFIZER INC. ($376.60) |
| 2017 | $2,342 | 189 | Novo Nordisk Inc ($266.88) |
All Payment Transactions
1,433 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Obesity | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: PAIN | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.39 | General |
| Category: Cardiovascular | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Gastroenterology | ||||||
| 11/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Obesity | ||||||
| 10/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,112 | 1,837 | $215,877 | $128,440 |
| 2022 | 15 | 721 | 1,063 | $144,313 | $69,841 |
| 2021 | 24 | 1,076 | 1,587 | $221,128 | $111,103 |
| 2020 | 23 | 941 | 1,422 | $196,573 | $91,746 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 20 | 24 | $1,080 | $924.00 | 85.6% |
| 99439 | Chronic care management services, each additional 20 minutes of clinical staff time per calendar month | Office | 2021 | 12 | 27 | $1,080 | $758.42 | 70.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 13 | 24 | $1,560 | $733.93 | 47.0% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 17 | 17 | $765.00 | $616.00 | 80.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 31 | 36 | $1,440 | $346.20 | 24.0% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 12 | 12 | $370.00 | $312.07 | 84.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 18 | 18 | $810.00 | $279.30 | 34.5% |
| 90471 | Administration of 1 vaccine | Office | 2021 | 11 | 11 | $435.00 | $118.08 | 27.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 15 | 19 | $133.00 | $54.00 | 40.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 140 | 391 | $63,635 | $26,432 | 41.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 81 | 186 | $29,750 | $14,622 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 85 | 85 | $9,775 | $9,377 | 95.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 140 | 200 | $22,000 | $8,510 | 38.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 46 | 89 | $9,790 | $5,051 | 51.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 83 | 83 | $5,845 | $4,941 | 84.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2020 | 15 | 15 | $8,250 | $2,828 | 34.3% |
| 45384 | Removal of polyps or growths in large bowel using an endoscope | Facility | 2020 | 21 | 21 | $16,170 | $2,812 | 17.4% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 13 | 13 | $3,575 | $2,722 | 76.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 16 | 16 | $2,800 | $2,610 | 93.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 17 | $5,185 | $2,577 | 49.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 11 | 11 | $1,870 | $1,666 | 89.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 13 | 13 | $1,950 | $1,543 | 79.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 93 | 94 | $4,230 | $1,497 | 35.4% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 11 | 16 | $2,560 | $1,210 | 47.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 18 | 19 | $2,090 | $1,039 | 49.7% |
About Dr. Daniel Kambic, DO
Dr. Daniel Kambic, DO is a Family Medicine healthcare provider based in Steelton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487616991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Kambic, DO has received a total of $21,476 in payments from pharmaceutical and medical device companies, with $3,546 received in 2024. These payments were reported across 1,433 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($21,394).
As a Medicare-enrolled provider, Kambic has provided services to 3,850 Medicare beneficiaries, totaling 5,909 services with total Medicare billing of $401,130. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Steelton, PA
- Active Since 04/03/2006
- Last Updated 04/25/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487616991
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,309
- JARDIANCE (Drug) $1,242
- XIFAXAN (Drug) $1,030
- FARXIGA (Drug) $823.99
- Ozempic (Drug) $815.95
- VRAYLAR (Drug) $800.84
- BREZTRI (Drug) $643.85
- Kerendia (Drug) $583.50
- MOUNJARO (Drug) $569.07
- Saxenda (Drug) $546.73
- XARELTO (Drug) $476.09
- Vascepa (Drug) $458.87
- STIOLTO RESPIMAT (Drug) $448.42
- EVENITY (Biological) $418.79
- TRULICITY (Drug) $417.80
- Wegovy (Drug) $393.25
- NURTEC ODT (Drug) $388.98
- SYMBICORT (Drug) $373.48
- QULIPTA (Drug) $364.19
- Aimovig (Biological) $359.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Steelton
Kaitlin Plummer, Do, DO
Family Medicine — Payments: $14,016
Arif Shaikh, Md, MD
Family Medicine — Payments: $3,394
William Wewer, D.o, D.O
Family Medicine — Payments: $3,236
Deanne Endy, Do, DO
Family Medicine — Payments: $1,383
Maryjo Szada, Md, MD
Family Medicine